Orthopediatrics (KIDS) Cost of Revenue (2016 - 2026)

Orthopediatrics (KIDS) has reported Cost of Revenue for 11 consecutive years, with $18.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 6.32% year-over-year to $18.1 million in Q2 2026; TTM through Jun 2026 was $66.6 million, a 5.99% increase from a year earlier, with the FY2025 full-year figure at $63.7 million, up 13.47% from the prior year.
• Cost of Revenue was $18.1 million for Q2 2026 at Orthopediatrics, up from $16.0 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $18.1 million in Q2 2026 and troughed at $4.9 million in Q1 2022.
• A 5-year average of $12.4 million and a median of $12.3 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue decreased 5.57% in 2022 and soared 65.47% in 2023, its largest moves.
• Over 5 years, Cost of Revenue stood at $9.8 million in 2022, then grew by 11.56% to $10.9 million in 2023, then jumped by 56.91% to $17.1 million in 2024, then declined by 3.53% to $16.5 million in 2025, then gained by 9.96% to $18.1 million in 2026.
• The last three Cost of Revenue figures came in at $18.1 million (Q2 2026), $16.0 million (Q1 2026), and $16.5 million (Q4 2025), per Business Quant data.